These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18049125)

  • 1. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival.
    Truong W; Plester JC; Hancock WW; Kaye J; Merani S; Murphy KM; Murphy TL; Anderson CC; Shapiro AM
    Transplantation; 2007 Nov; 84(10):1368-72. PubMed ID: 18049125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts.
    Truong W; Plester JC; Hancock WW; Merani S; Murphy TL; Murphy KM; Kaye J; Anderson CC; Shapiro AM
    Am J Transplant; 2007 Dec; 7(12):2663-74. PubMed ID: 17983390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
    Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
    Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
    del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
    Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 10. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
    Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
    Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
    Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
    Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of anti-CD103 immunotoxin for saving islet allograft in context of transplantation.
    Zhang L; Hadley GA
    Chin Med J (Engl); 2010 Dec; 123(24):3644-51. PubMed ID: 22166645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local CTLA4Ig synergizes with one-dose anti-LFA-1 to achieve long-term acceptance of pancreatic islet allografts.
    Chahine AA; Yu M; McKernan M; Stoeckert C; Linsley PS; Lau HT
    Transplant Proc; 1994 Dec; 26(6):3296. PubMed ID: 7998139
    [No Abstract]   [Full Text] [Related]  

  • 16. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
    Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
    Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival.
    Nanji SA; Hancock WW; Anderson CC; Zhu LF; Kneteman NM; Shapiro AM
    Transplant Proc; 2003 Nov; 35(7):2477-8. PubMed ID: 14611990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
    Truong W; Hancock WW; Anderson CC; Merani S; Shapiro AM
    Cell Transplant; 2006; 15(2):105-19. PubMed ID: 16719045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.